ArrowMark Colorado Holdings’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-44,856
Closed -$28.5M 352
2022
Q1
$28.5M Sell
44,856
-41,383
-48% -$26.1M 0.25% 102
2021
Q4
$76.8M Sell
86,239
-5,942
-6% -$6.24M 0.62% 47
2021
Q3
$117M Sell
92,181
-18,255
-17% -$22.1M 0.91% 30
2021
Q2
$134M Sell
110,436
-465
-0.4% -$627K 1.01% 26
2021
Q1
$147M Buy
110,901
+5,347
+5% +$7.57M 1.1% 25
2020
Q4
$142M Buy
+105,554
New +$121M 1.1% 27

Other funds holding CANO

ArrowMark Colorado Holdings's CANO Position: Q2 2022 in Review

ArrowMark Colorado Holdings sold out of Cano Health, Inc. (CANO) in Q2 2022, closing a stake of 44,856 shares — an estimated $28.5M sold.

ArrowMark Colorado Holdings first reported a position in CANO in Q4 2020 and held it in 6 quarters. The position peaked at $147M in Q1 2021. 144 funds tracked by Wall St. Rank hold CANO as of Q2 2022.

  • ArrowMark Colorado Holdings reported no remaining Cano Health, Inc. position as of Q2 2022 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 44,856 Cano Health, Inc. shares in Q2 2022, an estimated $28.5M.
  • ArrowMark Colorado Holdings first reported a position in Cano Health, Inc. in Q4 2020 and held it in 6 quarters.
  • ArrowMark Colorado Holdings's Cano Health, Inc. position peaked at $147M in Q1 2021.
  • 144 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q2 2022.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2022, filed 15 Aug 2022.